Offer - Urjas Oil for just ₹ 1 X
Megapose Plus is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Depression.
The right dosage of Megapose Plus depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
These side effects of Megapose Plus are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Megapose Plus is Not Used By Women for pregnant women and Not Used By Women for women who are breastfeeding. Further, the section on Megapose Plus related warnings talks about Megapose Plus's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Megapose Plus contraindications section.
Drug interactions for Megapose Plus have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Megapose Plus, it is important to know that it is not safe while driving, and is not habit-forming.
Megapose Plus is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Megapose Plus safe for pregnant women?
Not Used by Women
Is the use of Megapose Plus safe during breastfeeding?
Not Used by Women
What is the effect of Megapose Plus on the Kidneys?
Megapose Plus can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Megapose Plus on the Liver?
The liver can be affected by Megapose Plus. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Megapose Plus only after medical advice.
What is the effect of Megapose Plus on the Heart?
There is no research available on the side effects of Megapose Plus on the heart. Therefore, its impact is unknown.
Megapose Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Unknown
If you are suffering from any of the following diseases, you should not take Megapose Plus unless your doctor advises you to do so -
Is this Megapose Plus habit forming or addictive?
You may get addicted to Megapose Plus. Therefore, before taking it, consult your doctor.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Megapose Plus as you may feel sleepy.
Is it safe?
Yes, but consume Megapose Plus only on doctor's advice.
Is it able to treat mental disorders?
Yes, this Megapose Plus works for mental disorders.
Interaction between Food and Megapose Plus
There isn't any research available on the side effects of taking Megapose Plus with food.
Interaction between Alcohol and Megapose Plus
Side effects of drinking alcohol and taking Megapose Plus at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522